Workshops
The CRISPRMED26 workshops co-organised with GenE-HumDi (GHD) COST Action and experts from our community, offer students an interactive opportunity to acquire critical applied knowledge and skills that will expand their profile in the gene-editing field.
With a limited number of 30 places per workshop, we focus on delivering high-quality, interactive workshops in which you can learn by doing instead of just listening.
The CRISPRMED26/GenE-HumDi COST Action workshops will be facilitated by scientific leaders from the GenE-HumDi consortium. These experts will share their knowledge and experience in a practical, case-based setting that will allow you to apply what you learn directly to your professional career.
All you need to bring is a laptop!
Register for the workshops here.
Please contact us at info@crisprmedicineconference.com if you would like to be added to the waitlist.
CRISPRMED26 GHD workshops
The CRISPRMED26 workshops will be held from 9:00-13:30 CEST on the 14th April 2026.
Each workshop will last 1 hour and 25 minutes.
Workshop facilitators: TBD
This workshop will be faciliated by: TBD
The workshop will start with an introduction to various genome-editing technologies highlighting their mechanisms, advantages, and limitations.
We will also discuss recent developments in genome-editing tools, focusing on those DSB-free and with demonstrated therapeutic potential, such as base- and prime editing. Next, we will cover criteria for selecting the appropriate genome-editing tool based on the targeted disease and present case studies of therapeutic applications.
We will emphasise that different diseases require distinct genome-editing strategies depending on the aim, such as gene replacement, gene restoration, or gene insertion.
The workshop will include a hands-on session with practical demonstrations and group activities to design genome-editing experiments. Finally, we will address ethical and safety considerations, emphasising regulatory guidelines and best practices.
The workshop will be highly interactive, with Q&A sessions throughout, pausing at key points for discussion.
This workshop will be faciliated by: TBD
This workshop will focus on navigating the current landscape of viral- and non-viral delivery methods for CRISPR gene-editing tools.
The session will provide the participants a broad and comparative introduction on the various delivery methods available for the different CRSPR gene-editing tools, their advantages and disadvantages.
Importantly, the workshop will try to achieve a comprehensive understanding on how to select the right delivery tool for a specific CRISPR gene editing in cells to achieve high efficacy, the so-called “CRISPR-Delivery-Cell, CDC” match-making procedure.
This workshop will be faciliated by: TBD
This workshop will focus on the side effects derived from the use of genome editors. The session will address the risks associated with the unspecific activity of CRISPR-based platforms, which can impact both the safety and efficacy of gene-editing approaches. Participants will gain a comprehensive understanding of the different types of potential genotoxic events and of the different methods available to monitor unintended genomic modifications, including those aligned with regulatory guidelines:
- Off-target activity of genome editors
- Genotoxicity: on- and off-target aberrations
- Off-target evaluation methods
- Mitigation strategies
- Hands-on basic training on specificity prediction
CRISPRMED26 workshops special (NEW 2026)
The CRISPRMED26 workshops will be held from 9:00-13:30 CEST on the 14th April 2026.
Each workshop will last 1 hour and 25 minutes.
This workshop will be faciliated by: Fredrik Wermeling, Karolinska Institutet, Sweden
This workshop introduces practical approaches to analyzing CRISPR screen data, focusing on how to interpret results and identify biologically meaningful targets.
It is aimed at participants with limited bioinformatics experience and will demonstrate accessible strategies and online tools for exploring and prioritizing genes identified in screening experiments.
Examples will include both participants’ own CRISPR screen data and publicly available datasets such as DepMap.
This workshop will be faciliated by Yonglun Luo, Aarhus University, Denmark and Jan Gorodkin, University of Copenhagen, Denmark
The workshop will introduce data generation for and the development of deep-learning-based prediction models for CRISPR gRNA on-target activity editing outcomes for base editors. Strategies for specificity (off-targets) analysis will be introduced as well
We will also discuss recent developments in AI, deep-learning, and machine learning tools, focusing on base- and prime editing.
The workshop will include a hands-on session with practical demonstrations and cases to design Cas9 and base editing gRNAs using the CRISPRon, CRISPRon-ABE/CBE tools. Finally, we will explore and discuss the application of CRISPR AI or co-pilot for gRNA design.
The workshop will be highly interactive, with Q&A sessions throughout, pausing at key points for discussion.
About GenE-HumDi - Genome Editing for the Treatment of Human Disease Network
The principal aim of the GenE-HumDi Action is to bring together pharmaceutical companies, academic institutions, science and regulatory agencies, biotechnology firms, patient advocacy associations and information technology, in order to tackle knowledge fragmentation with the aim to accelerate the translation of gene-editing technologies for the treatment of human diseases.
GenE-HumDi is supported by COST (European Cooperation in Science and Technology), which is a funding organisation for research and innovation networks operating in Europe since 1971. In their organisation, GenE-HumDi nourishes from the idea exchange of Management Committee (MC) members from over 24 EU Countries. MC and other members are organised into Working Groups (WG) to distribute GenE-HumDi's workload and allocate specific questions to dedicated experts in each field.
Dr Karim BENABDELLAH
Action Chair
0034958 715 500
Dr Alessia CAVAZZA
Action Vice Chair
02079052787